Skip to main content
. 2019 Aug 31;22(6):870–877. doi: 10.1007/s12094-019-02197-6

Fig. 2.

Fig. 2

Trend for reduced overall survival in circulating tumour cell (CTC)-positive metastatic breast cancer patients. CTC number in 7.5 ml peripheral whole blood samples enumerated by the CellSearch technology was enumerated in metastatic breast cancer (MBC) patients. Log-rank (Mantel–Cox) testing compared survival in days from study entry in CTC-positive compared to CTC-negative patients. CTC positive defined as ≥ 1/7.5 ml. Assumption of proportionality was verified based on Schoenfeld residuals; n number of MBC patients in each group, CTC circulating tumour cell